-
Bayer To Cut 12,000 Jobs Following Monsanto Purchase
Monday, December 3, 2018 - 12:01pm | 417Read More...Earlier this year, German pharmaceutical company Bayer AG (OTC: BAYRY) announced its $60-million acquisition of Monsanto. The agrochemical company recently faced litigation tied to its weedkiller RoundUp. What Happened Bayer will cut roughly 12,000 jobs globally by the end...
-
Jefferies Downgrades AstraZeneca, Sees Limited Additional Upside
Thursday, August 16, 2018 - 11:05am | 402Read More...The best kind of analyst downgrade for investors is the one that comes because a stock has performed so well that it has exceeded expectations. On Thursday, AstraZeneca plc (ADR) (NYSE: AZN) was hit with just such a downgrade. The Analyst Jefferies analyst Ian Hilliker downgraded AstraZeneca from...
-
Jefferies Raises Pfizer PT, Says Company Has Multiple Ways To Win
Monday, March 23, 2015 - 9:36am | 180Read More...Jefferies on Monday issued a report on Pfizer Inc. (NYSE: PFE), raising its price target from $42 to $45. Jefferies rates Pfizer as a Buy. Analysts Jeffrey Holland, David Gu, Ian Hilliker and Sissi Qiong Hai wrote, "We expect Pfizer shares to significantly appreciate over the next 1-2 years based...
